Representing Glenmark in a federal antitrust multidistrict litigation alleging price fixing and market allocation of generic drugs by manufacturers of generic drugs.
Representing a major financial institution in federal antitrust class and individual actions alleging that the payment card practices of the defendant card networks and financial institutions constitute an unreasonable restraint of trade and illegal monopolization. This is likely the largest private antitrust case ever brought.
Representing wire manufacturer in antitrust and false-advertising suit against three major copper wire competitors.
Represented Sprint and SoftBank before DOJ/FCC and at trial against multiple State Attorneys’ General seeking to block the T-Mobile-Sprint merger as anti-competitive. After a two-week trial, the Court dismissed the case and the merger closed successfully.
Represented SoftBank Group and Arm Limited on complex antitrust and national security issues arising from NVIDIA’s proposed acquisition of Arm from SoftBank for $65 billion.
Obtained antitrust regulatory clearances in connection with Southwest Gas Holdings’ $2 billion acquisition of Questar Pipeline and subsequent sale of certain assets.
Represented digital programmatic healthcare advertising firm in lawsuit seeking to block.
Representing a contact lens manufacturer in antitrust litigation pending against unauthorized distributors.
Won dismissal of antitrust lawsuit against SoftBank.
Won dismissal of class action antitrust litigation arising out of the introduction of chip card standards to the US payments sector.